News

Friedman Industries Reports Impressive First Quarter Growth

Friedman Industries Reports Impressive First Quarter Growth

Friedman Industries Reports Significant First Quarter Growth

Friedman Industries, Incorporated (NASDAQ/GS: FRD) has announced remarkable results for the first quarter of the fiscal year, showcasing a strong performance that has positioned the company favorably in the steel manufacturing sector. The results released highlight not only the growth in earnings but also an increase in sales compared to previous quarters.

First Quarter Highlights at a Glance

The quarter ending June 30 has brought impressive figures indicating a healthy trajectory for Friedman Industries. Sales reached an impressive $134.8 million, reflecting a 12% year-over-year increase in tons sold. This performance culminated in net earnings of around $5.0 million, reinforcing confidence in the company's operational strategies. Operating cash flow also showed strength, registering $15.5 million, alongside a notable debt reduction of $14.7 million.

Performance Overview

Michael J. Taylor, the President and Chief Executive Officer, expressed satisfaction with the quarterly results, emphasizing how enhanced sales volume and improved profit margins contributed to the positive earnings. The previous quarter, which ended June 30, 2024, reported net earnings of $2.6 million on sales of $114.6 million, demonstrating Friedman’s notable improvement.

The increase in sales volumes during this recent quarter included approximately 141,500 tons of inventory sold and an additional 19,000 tons from toll processing agreements. This marks an increase from the previous year's figures, which included around 119,000 tons from inventory and 24,000 tons from toll processing. This growth is attributed to heightened demand and proactive sales strategies to maximize facility capacities.

Unaudited Operational Snapshots

The company has provided a summarized account of its operations for the recent quarters, depicting a clear distinction in performance metrics between 2025 and 2024:

Operational Performance Metrics

Friedman Industries continues to exhibit robust financial health, with key operational metrics indicating growth across various segments. Net sales garnered in the flat-roll segment reached approximately $124.1 million for the 2025 quarter, a jump from $103.4 million the previous year. This sector alone accounted for a sales volume of about 132,500 tons from inventory and another 19,000 tons via toll processing.

Simultaneously, the tubular segment experienced slight fluctuations in sales, totaling around $10.7 million during the most recent quarter, compared to $11.2 million in the 2024 quarter. Despite a drop in sales volume, the average selling price for tubular products increased, showcasing a strategic pricing mechanism in response to market conditions.

Hedging Activities and Financial Strategy

Friedman Industries implements a strategic approach to manage risks through hedging activities, notably utilizing hot-rolled coil (HRC) futures. This financial strategy aims to mitigate the impact of price volatility on unsold inventory while ensuring the predictability of revenue streams. In the first quarter results, reported gains on hedging activities amounted to approximately $0.3 million, demonstrating the effectiveness of the company's risk management protocols.

Future Outlook and Strategic Directions

Looking forward, Friedman expects to see a continuation of higher sales volumes as operational efficiencies are pursued. In context, with recent disparities in HRC pricing, projections indicate a temporary dip in margins for the upcoming quarter. However, Michael J. Taylor remains optimistic regarding longer-term growth, believing in the inherent strength of the industry and the capabilities of his team to navigate challenges.

With a solid foundation, Friedman Industries is well-positioned to take advantage of both immediate and long-term opportunities in the market, ensuring it remains agile in a dynamically changing economic landscape.

About Friedman Industries

Friedman Industries, Incorporated is a Texas-based manufacturer and processor of steel products. The company operates across several plants, offering both flat-roll and tubular product solutions. These operations span multiple locations, ensuring a diverse portfolio and broad market reach, enhancing their capacity to meet customer demands effectively.

Frequently Asked Questions

What are the recent earnings of Friedman Industries?

Friedman Industries reported net earnings of approximately $5.0 million for the first quarter of fiscal 2026.

How did the sales figures change from the previous quarter?

Sales increased to $134.8 million, marking a 12% increase in tons sold year-over-year.

What is the outlook for Friedman Industries in the upcoming quarters?

The company anticipates slightly higher sales volumes but expects lower margins compared to the first quarter.

What strategy does Friedman Industries employ for risk management?

Friedman uses hot-rolled coil futures to manage price risk on unsold inventory and ensures consistent financial results.

How many tons of inventory did Friedman sell this quarter?

Friedman sold approximately 141,500 tons of inventory in the most recent quarter.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles